GlobalData on MSN
Preclinical model drawbacks dampen UK innovation, ABPI report says
The ABPI says that industry and academia must come together to bridge the gap between academic and commercially ready preclinical models.
Cinclus Pharma Holding AB (publ), a late-stage clinical pharmaceutical company developing next-generation treatments for gastric acid-related diseases, today announced that the US Food and Drug Admini ...
GSK’s own proprietary platform is called Cogito Forge. It is not a standard AI search model, but one that uses ‘agents’ that can debate with each other. One proposes a target, another simulates its ...
Researchers report that pairing two known medicines reduced liver fibrosis in mice, offering a possible path toward scar ...
To be successful in the pharmaceutical industry, leaders must be willing to take risks. During his conversation with Pharmaceutical Executive, Leonard Mazur kept coming back to this point. According ...
Explore the latest advancements in Alzheimer’s drug research, revealing hope for earlier diagnosis and new treatment options.
Rising Outsourcing of Clinical, Regulatory, and Data Management Functions Strengthens Global Adoption Across Pharmaceutical, Biotech, and Medical Device Industries.Austin, United States, Feb. 13, 2026 ...
HCW Biologics receiving cash fee and co-founder shares in Trimmunevalued at $7.0 millionTrimmune will hold exclusive worldwide license for rights ...
iX Biopharma has been awarded a US$40.95 million development contract by the US Department of Defense to fund the development of Wafermine®, its patented sublingual ketamine wafer for the treatment of ...
Crysvita revenue of $481 million and Dojolvi revenue of $96 million 2026 total revenue from current products expected to be between $730 million to $760 million Initiated ...
By Bhanvi Satija and Maggie Fick LONDON, Feb 13 (Reuters) - Sanofi's incoming CEO, 65-year-old Belén Garijo, faces a major task to win over investors, accelerate the French company's stalled drug ...
PTC Therapeutics withdrew its New Drug Application (NDA) resubmission for Translarna (ataluren) in nonsense mutation Duchenne muscular dystrophy (nmDMD) following feedback from FDA indicating that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results